The Journal of Neuroscience, December 10, 2008, 28(50):13574-13581; doi:10.1523/JNEUROSCI.4099-08.2008
Previous Article | Next Article 
Neurobiology of Disease
Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis
Marcelo R. Vargas,1
Delinda A. Johnson,1
Daniel W. Sirkis,1
Albee Messing,2,3 and
Jeffrey A. Johnson1,2,4,5
1Division of Pharmaceutical Sciences, 2Waisman Center, 3Department of Comparative Biosciences, 4Molecular and Environmental Toxicology Center, and 5Center for Neuroscience, University of Wisconsin–Madison, Madison, Wisconsin 53705-2222
Correspondence should be addressed to Dr. Jeffrey A. Johnson, School of Pharmacy, 6125 Rennebohm Hall, University of Wisconsin–Madison, Madison, WI 53705-2222. Email: jajohnson{at}pharmacy.wisc.edu
Activation of the transcription factor Nrf2 in astrocytes coordinates the upregulation of antioxidant defenses and confers protection to neighboring neurons. Dominant mutations in Cu/Zn-superoxide dismutase (SOD1) cause familial forms of amyotrophic lateral sclerosis (ALS), a fatal disorder characterized by the progressive loss of motor neurons. Non-neuronal cells, including astrocytes, shape motor neuron survival in ALS and are a potential target to prevent motor neuron degeneration. The protective effect of Nrf2 activation in astrocytes has never been examined in a chronic model of neurodegeneration. We generated transgenic mice over-expressing Nrf2 selectively in astrocytes using the glial fibrillary acidic protein (GFAP) promoter. The toxicity of astrocytes expressing ALS-linked mutant hSOD1 to cocultured motor neurons was reversed by Nrf2 over-expression. Motor neuron protection depended on increased glutathione secretion from astrocytes. This protective effect was also observed by crossing the GFAP-Nrf2 mice with two ALS-mouse models. Over-expression of Nrf2 in astrocytes significantly delayed onset and extended survival. These findings demonstrate that Nrf2 activation in astrocytes is a viable therapeutic target to prevent chronic neurodegeneration.
Key words: Nrf2; astrocytes; glutathione; motor neurons; neuronal death; neuroprotection
Received Aug. 27, 2008;
revised Oct. 8, 2008;
accepted Nov. 5, 2008.
Correspondence should be addressed to Dr. Jeffrey A. Johnson, School of Pharmacy, 6125 Rennebohm Hall, University of Wisconsin–Madison, Madison, WI 53705-2222. Email: jajohnson{at}pharmacy.wisc.edu
This article has been cited by other articles:

|
 |

|
 |
 
K.-H. Kim, J.-Y. Jeong, Y.-J. Surh, and K.-W. Kim
Expression of stress-response ATF3 is mediated by Nrf2 in astrocytes
Nucleic Acids Res.,
October 28, 2009;
(2009)
gkp865v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kim and P. K. Y. Wong
Oxidative Stress Is Linked to ERK1/2-p16 Signaling-mediated Growth Defect in ATM-deficient Astrocytes
J. Biol. Chem.,
May 22, 2009;
284(21):
14396 - 14404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-C. Chen, M. R. Vargas, A. K. Pani, R. J. Smeyne, D. A. Johnson, Y. W. Kan, and J. A. Johnson
Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte
PNAS,
February 24, 2009;
106(8):
2933 - 2938.
[Abstract]
[Full Text]
[PDF]
|
 |
|